Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma
Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma (FREYA)
Professor Klaus Bønnelykke
2,000 participants
Dec 20, 2024
INTERVENTIONAL
Conditions
Summary
The overall aim of the study is to develop a nutritional preventive fish oil supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that both supplementations in higher doses than recommended could reduce the risk of disease development.
Eligibility
Inclusion Criteria4
- Pregnant Danish women before week 26 with blood levels of EPA+DHA below 4.7% of total fatty acids
- No planned use of fish oil supplementations
- No endocrine-, heart-, kidney- or auto-immune disorders
- No disorders requiring treatment with blood thinning medication
Interventions
Oral intake of 4 capsules per day from week 22-26 in pregnancy to 1 week after delivery
Oral intake of 4 capsules per day from week 22-26 in pregnancy to 1 week after delivery
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06560255